report revenu ebitda consensu guid
big surpris q/q increas us ad revenu massiv
outpac normal season trend digit drove upsid quarter twitter
continu make stride improv health platform weigh
mau dau posit long term overal perform
solid challeng sentiment backdrop past month
posit us ad revenue growth y/i q/q well ahead estim
strength across twtr big account video web-card continu gain
traction possibl also benefit price lack nf inventori fb
could continu world vs may also
play role us growth data licens steadi y/i
gnip strong limit impact mopub reiter long term margin
goal eas concern around safety/secur de-lever seen peer
neg trend monitor ad revenu growth continu deceler
japan vs ex-fx row vs ex-fx last qtr dau growth
deceler half top remain doubl digit mobil
outpac averag overal figur weigh desktop declin spam
clean-up mau q/q heaviest declin record gdpr sm
health notif bug issu guid mau
estim valuat rais revenue ebitda respect
given consist upsid estim also rais target multipl
revenu remain sidelin think share reflect optim
ebitda compar fb
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
given larg oper loss premium
ev/ebitda multipl fb/googl
upsid case base blend averag
bull case revenu bull
case ebitda higher
current estim
downsid case base blend averag
bear case revenu
bear case ebitda lower
current estim
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
usd mn unless note barclaysprior yearchang chang actualestimatestreetquarterprior yearprior qkey statementadvertis profit bpsoper expens ex-sbc sale compens oper oper oper ebitda bpsinterest income/ expens tax expens tax net net per vs barclay barclay inc
figur summari estim chang
new estimate old estimate deltanew estimate old estimate deltanew estimate old estimate deltanew estimate old estimate deltamau eoy twtrunit statementadvertis good profit bpsoper expens ex-sbc sale compens oper oper ebitda margin bpsinterest income/ expens net net barclay inc
rais pt base revenu vs revenu previous
ebitda blend averag estim
consist prior methodolog
-- valuat worksheet million except per share amount current price share market enterpris ev ev/revenu ye ye minor market end project stock price forward ev/ebitda ye ye minor market end project stock price forward barclay inc
-- quarterli earn ajun asep adec emar ejun esep edec gross revenu ex fit expensesresearch compens oper base expens incom tax expens net oper net incom attribut particip incom attribut class class earn per share earn per forma earn per share forma share metricsfre cash peer per analysisgross fit sale net develop net administr net oper expens net oper oper ebitda margin net ebitda tax net year growthadvertis licens oper net earn per forma earn per barclay inc
ross sandler deepak mathivanan herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli
indirectli relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
